Latest Meningococcal Disease Research

MMWR: Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years Recommendations of the Advisory Committee on Immunization Practices ― United States, 2023

MMWR: Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey–Teen, United States, 2022

ACIP Meeting Feb. 2024: Revising the Adolescent Meningococcal Vaccine Schedule: Term of Reference and Considerations Revising the Adolescent Meningococcal Vaccine Schedule: Term of Reference and Considerations

ACIP-VFC Resolution - Vaccines To Prevent Meningococcal Disease

Meningitis B has been responsible for all US college outbreaks of meningococcal disease since 2011

Achieving high MenB vaccination coverage is necessary to help protect persons during outbreaks of meningococcal disease caused by serogroup B